A Registry Study on Serumal Biomarkers About Adverse Events in Patients Undergoing Coronary Artery Bypass Grafting.

NCT04107571 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2019-09-27

No results posted yet for this study

Summary

This is a national registry study to determine the serumal biomarkers for prognosis of adverse events in patients undergoing coronary artery bypass grafting.

Conditions

  • Cardiac Surgery

Interventions

PROCEDURE

A type of operation for coranary heart disease patients.

A type of operation for coranary heart disease patients.

Sponsors & Collaborators

  • Beijing Institute of Heart, Lung and Blood Vessel Diseases

    lead OTHER

Principal Investigators

  • Jie Du, PHD · Beijing Anzhen Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2024-01-31
Completion
2024-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04107571 on ClinicalTrials.gov